Cash/Share of Supernus Pharmaceuticals, Inc.
Cash per share, sometimes called the cash share ratio, is the total cash per share. Cash on hand is reported on the balance sheet. Cash per share is calculated by dividing cash on hand by the total number of shares. Cash per share is the percentage of a firm's share price that is immediately accessible for spending. Cash per share consists of cash and short-term investments. It is money that a firm has on hand and does not come from borrowing or financing activities.
When a firm has a high cash per share, significant percentage of its assets is in a very liquid form. This can indicate economic uncertainty and unwillingness to invest given the current economic climate. High levels of cash per share can indicate that a firm is performing well and is able to reinvest in itself but high cash per share does not always indicate overall financial strength.
Cash/Share of companies in the Health Care sector on NASDAQ compared to Supernus Pharmaceuticals, Inc.
Supernus Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system diseases in the United States. It offers Oxtellar XR, an extended-release oxcarbazepine for use in the treatment of epilepsy; and Trokendi XR, an extended-release topiramate, which is used for the treatment of epilepsy. The company's product candidates comprise SPN-810, a molindone hydrochloride that is in Phase III clinical trial for the treatment of impulsive aggression in patients with attention deficit hyperactivity disorder (ADHD); and SPN-812, a viloxazine hydrochloride, which has completed Phase IIb trial that is used for the treatment of ADHD. It also develops SPN-809, a viloxazine hydrochloride, which is in Phase II ready clinical trial for the treatment of depression. The company markets its products through wholesalers and pharmaceutical distributors. Supernus Pharmaceuticals, Inc. was founded in 2005 and is based in Rockville, Maryland.
- Supernus Pharmaceuticals, Inc., 1550 East Gude Drive, Rockville 20850, United States
Companies with Cash/Share similar to Supernus Pharmaceuticals
|GNRT Gener8 Maritime, Inc.||NYSE > Transportation > Marine Transportation||2.23|
|MITT AG Mortgage Investment Trust, Inc.||NYSE > Finance > REIT - Diversified||2.23|
|CRI Carter's, Inc.||NYSE > Consumer Non-Durables > Apparel||2.23|
|VVUS VIVUS, Inc.||NASDAQ > Health Care > Major Pharmaceuticals||2.23|
|RNG Ringcentral, Inc.||NYSE > Technology > EDP Services||2.23|
|ZEN Zendesk, Inc.||NYSE > Technology > EDP Services||2.23|
|SUPN Supernus Pharmaceuticals, Inc.||NASDAQ > Health Care > Major Pharmaceuticals||2.24|
|PCO Pendrell Corporation||NASDAQ > Miscellaneous > Multi-Sector Companies||787.71|
|IFRX InflaRx N.V.||NASDAQ||961.67|
|GS Goldman Sachs Group, Inc. (The)||NYSE > Finance > Investment Bankers/Brokers/Service||1,092.87|
|SEB Seaboard Corporation||NYSEMKT > Finance > Investment Bankers/Brokers/Service||1,212.25|
|BRK-A Berkshire Hathaway Inc.||NYSE > Finance > Property & Casualty Insurance||61,434.44|
|BRK-B Berkshire Hathaway Inc.||NYSE > Finance > Property & Casualty Insurance||61,434.44|